Latest News & Events - Graves' Disease and Thyroid Foundation
Get support and expert info on Graves' Disease and TED at GDATF. Join our community for educational tools, advocacy, and the latest thyroid research.
gdatf.orgGraves’ disease symptoms mostly come from hyperthyroidism (an overactive thyroid) and, in some people, thyroid eye disease. Common symptoms include a fast or irregular heartbeat, tremor/shakiness, heat intolerance with sweating, unexplained weight loss, increased appetite, anxiety/irritability, and fatigue; some people also notice an enlarged thyroid/neck swelling.[7][8]
Body/thyroid (hyperthyroid)
Neck/thyroid gland
Eyes (thyroid eye disease/TED)
Get urgent medical care if you have symptoms suggesting complications—especially chest pain, fainting, severe shortness of breath, or markedly irregular heartbeat—because untreated hyperthyroidism can stress the heart.[7]
Recent coverage has focused on therapies targeting Graves-related complications such as Graves’ eye disease, describing monitoring for progression symptoms like proptosis, eyelid swelling, pain, and double vision.[3]
If you tell me your age, symptoms you’re having, and how long they’ve been going on, I can help you map them to the typical Graves’ symptom patterns and what clinicians usually check next.
Get support and expert info on Graves' Disease and TED at GDATF. Join our community for educational tools, advocacy, and the latest thyroid research.
gdatf.orgGraves' disease is a condition of the immune system that leads to an overactive thyroid. It is caused by antibodies attacking the thyroid by mistake. The thyroid and the hormones it produces are the gas pedal for the body. When someone produces too much thyroid hormones, the body goes into overdrive. Your pulse increases, you overheat, you lose sleep — these symptoms make people feel so unwell that they seek medical attention. This is what leads to additional testing and the diagnosis of...
medicalxpress.comApitope announced positive results from the Phase I first in man clinical trial of its product candidate, ATX-GD-59, in development for the treatment of Graves' disease.
www.americanpharmaceuticalreview.comThis autoimmune disorder causes the thyroid gland to produce too much thyroid hormone, leading to hyperthyroidism.
news.abplive.comSuccess of phase 3 trial evaluating teprotumumab for treatment of active thyroid eye disease (TED) brings drug closer to FDA approval.
www.michiganmedicine.org